🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New job posting alert! We're hiring a Vice President of Clinical Development to join our executive team and facilitate clinical strategy for our lead asset. Interested? Check out the full job description on our job board: job-boards.greenhouse.io/strandtherapeu…

How do you precisely control the timing and location of therapeutic protein expression? Strand Therapeutics develops first-in-class programmable #mRNA therapeutics. See how they use Benchling to speed up their process dev: benchling.com/customer-stori… #BuiltOnBenchling

Strand had the wonderful opportunity to host some fantastic students from the Princeton Biotech Group during their Boston trip. It was fun to answer questions about mRNA, biotech, being in the clinic, and more!

Happy Halloween from all of us at Strand! 🎃#Halloween #BiotechNews #Biotech #mRNAResearch #mRNA #mRNATherapies

Tomorrow is International Women's Day! Our team onsite is wearing purple and celebrating women's accomplishments today (and every day).💜#BioTech #InternationalWomensDay #IWD2025

Last week, Strands volunteered at Women's Lunch Place! They cooked and served hot meals to help women experiencing homelessness and poverty. Thanks for having us, Women's Lunch Place! #BiotechNews #Biotech #mRNAResearch #mRNA #mRNATherapies

Come by our poster today at #AACR25 to learn about the groundbreaking data from the preclinical program for STX-003 - a systemically delivered self-replicating mRNA encoding IL-12. Session Details: Date and Time: April 28, 2:00-5:00 pm CT Location: Section 37

Strand had the wonderful opportunity to host some fantastic students from MIT's BioCEL and Ron Weiss's lab. It was fun to answer questions about life sciences careers, mRNA, biotech, and more! 🔬🧬 #BiotechNews #Biotech #mRNAResearch #mRNA #mRNATherapies

Wishing all of the moms of Strand a happy Mother's Day! 💐 #MothersDay #BiotechNews #Biotech #mRNAResearch #mRNA #mRNATherapies

Over the weekend, Strands had the opportunity to volunteer at the #MassScienceFair Middle School State Fair! Shoutout to Gautam, Danish, Sanjana, Eloise, and Jaspreet for getting involved. #BeCurious #BiotechNews #Biotech #mRNAResearch #mRNA #mRNATherapies

Come by our poster presentation today at #ASGCT2025 to learn about exciting ongoing work for our STX-005 program! Session Details: Date and Time: May 13, 6:00-7:30 pm CT Abstract #781 Location: Hall I1-I2 annualmeeting.asgct.org

Come by our abstract presentation tomorrow at #ASGCT2025 to learn about the groundbreaking data from the preclinical program for STX-003. Session Title: Targeted Gene and Cell Therapy for Cancer Date and Time: May 17, 8:15-8:30 am CT Abstract Number: 394 Location: Room 291-292

Excited to share preliminary FIH Phase 1 data for STX-001: early signs of monotherapy activity and favorable safety in advanced solid tumors. Join us at ASCO: June 1, 9:00 AM-12:00 PM CDT, Abstract Number: 9556, Location: Hall A. Read our press release: businesswire.com/news/home/2025…

𝐀𝐒𝐂𝐎 𝟐𝟎𝟐𝟓: Strand Therapeutics's Co-Founder & CEO Jake Becraft discusses the clinical data presentation for the company's IL-12, self-replicating mRNA cancer immunotherapy. #ASCO25 Full video: biotechtv.com/post/strand-th…